Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22077 | 338 | 49.8 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MIR 210 | Author keyword | 47 | 66% | 13% | 43 |
| 2 | MICRORNA 210 | Author keyword | 22 | 81% | 4% | 13 |
| 3 | C19MC | Author keyword | 4 | 42% | 2% | 8 |
| 4 | HYPOXAMIR | Author keyword | 4 | 75% | 1% | 3 |
| 5 | C14MC | Author keyword | 2 | 67% | 1% | 2 |
| 6 | CHANGZHOU MATERN CHILD HLTH CARE HOSP | Address | 2 | 67% | 1% | 2 |
| 7 | MICRORNA MIR 210 | Author keyword | 1 | 100% | 1% | 2 |
| 8 | MIR 378A 5P | Author keyword | 1 | 50% | 1% | 2 |
| 9 | EPHRIN A3 | Author keyword | 1 | 33% | 1% | 2 |
| 10 | NEWBORN INFANTS | Address | 1 | 23% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MIR 210 | 47 | 66% | 13% | 43 | Search MIR+210 | Search MIR+210 |
| 2 | MICRORNA 210 | 22 | 81% | 4% | 13 | Search MICRORNA+210 | Search MICRORNA+210 |
| 3 | C19MC | 4 | 42% | 2% | 8 | Search C19MC | Search C19MC |
| 4 | HYPOXAMIR | 4 | 75% | 1% | 3 | Search HYPOXAMIR | Search HYPOXAMIR |
| 5 | C14MC | 2 | 67% | 1% | 2 | Search C14MC | Search C14MC |
| 6 | MICRORNA MIR 210 | 1 | 100% | 1% | 2 | Search MICRORNA+MIR+210 | Search MICRORNA+MIR+210 |
| 7 | MIR 378A 5P | 1 | 50% | 1% | 2 | Search MIR+378A+5P | Search MIR+378A+5P |
| 8 | EPHRIN A3 | 1 | 33% | 1% | 2 | Search EPHRIN+A3 | Search EPHRIN+A3 |
| 9 | ANTI FIBROTIC TREATMENT | 1 | 50% | 0% | 1 | Search ANTI+FIBROTIC+TREATMENT | Search ANTI+FIBROTIC+TREATMENT |
| 10 | BMSC DIFFERENTIATION | 1 | 50% | 0% | 1 | Search BMSC+DIFFERENTIATION | Search BMSC+DIFFERENTIATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MIR 210 | 28 | 54% | 11% | 37 |
| 2 | EPHRIN A3 | 18 | 89% | 2% | 8 |
| 3 | HSA MIR 210 | 15 | 82% | 3% | 9 |
| 4 | MICRORNA 210 | 13 | 69% | 3% | 11 |
| 5 | C19MC MICRORNAS | 11 | 78% | 2% | 7 |
| 6 | MIR 210 EXPRESSION | 6 | 80% | 1% | 4 |
| 7 | MICRORNA MIR 210 | 6 | 100% | 1% | 4 |
| 8 | PLACENTA SPECIFIC MICRORNAS | 4 | 75% | 1% | 3 |
| 9 | HUMAN PLACENTAS | 4 | 30% | 3% | 11 |
| 10 | C19MC | 2 | 38% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Multiple functions of hypoxia-regulated miR-210 in cancer | 2014 | 16 | 106 | 49% |
| Hypoxia-regulated microRNAs in human cancer | 2013 | 24 | 62 | 44% |
| Review: Placenta-specific microRNAs in exosomes Good things come in nano-packages | 2014 | 16 | 59 | 24% |
| miR-210: a therapeutic target in cancer | 2013 | 16 | 53 | 53% |
| miR-210: More than a Silent Player in Hypoxia | 2011 | 70 | 57 | 39% |
| miR-210: The Master Hypoxamir | 2012 | 56 | 99 | 22% |
| Prognostic Role of MicroRNA-210 in Various Carcinomas: A Systematic Review and Meta-Analysis | 2014 | 5 | 24 | 38% |
| Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases | 2013 | 13 | 37 | 38% |
| HypoxamiRs and Cancer: From Biology to Targeted Therapy | 2014 | 6 | 201 | 27% |
| miRNAs in pregnancy-related complications | 2015 | 0 | 77 | 60% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHANGZHOU MATERN CHILD HLTH CARE HOSP | 2 | 67% | 0.6% | 2 |
| 2 | NEWBORN INFANTS | 1 | 23% | 0.9% | 3 |
| 3 | CANC NANTONG | 1 | 50% | 0.3% | 1 |
| 4 | CARDIOL GANGNAM SEVERANCE HOSP | 1 | 50% | 0.3% | 1 |
| 5 | CELL CULTURE HIGH THROUGHPUT SCREENING CORE | 1 | 50% | 0.3% | 1 |
| 6 | GENOM EPIGEN BIOINFORMAT | 1 | 50% | 0.3% | 1 |
| 7 | MISTI | 1 | 50% | 0.3% | 1 |
| 8 | MOL BIOLMINIST EDUC | 1 | 50% | 0.3% | 1 |
| 9 | MOL BIOPHYSCARDIO X | 1 | 50% | 0.3% | 1 |
| 10 | ORTHOPAED SURG INTEGRATED HLTH SCI | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000199209 | RNA CARDIOVASC//IMTTS//MIR 133 |
| 2 | 0.0000165342 | MICRORNA//MIR 21//MICRORNAS |
| 3 | 0.0000129904 | GW182//DROSHA//ARGONAUTE |
| 4 | 0.0000118981 | MIR 140//MICRORNA 140//MICRORNA TARGET IDENTIFICATION |
| 5 | 0.0000111258 | DICER//DROSHA//MICROPROCESSOR COMPLEX |
| 6 | 0.0000105098 | NEUROTRAUMA VARIAT REGENERAT//TIANTAN HOSP//OTORHINOLARYNGOL MAXILLO IAL ONCOL |
| 7 | 0.0000098086 | MIR 34A//MICRORNA 34A//MIR 34 |
| 8 | 0.0000093658 | OBSTET FETAL MATERNAL MED//EXTRAVILLOUS TROPHOBLAST//TROPHOBLAST INVASION |
| 9 | 0.0000085303 | MOL DIABET//GDD GED TOXICOL//HARVARD PROGRAM THER EUT SCI |
| 10 | 0.0000083221 | MARC RUTI BELL VASC BIOL DIS PROGRAM//MIR 33//ABCA1 PROTEIN |